[1]
Almeida, C.B. et al. 2016. Use of tyrosine kinase inhibitors in the treatment of chronic myeloid leukemia (CML). Scientific Electronic Archives. 9, 5 (nov. 2016), 131–146. DOI:https://doi.org/10.36560/952016310.